Avacta Group Share News (AVCT)

Avacta sells Launch Diagnostics; reports "promising" efficacy data

(Alliance News) - Avacta Group PLC on Friday said it has agreed to sell its UK-based and largest diagnostics unit, Launch Diagnostics Holdings Ltd, and reported "promising" early efficacy data in the treatment of salivary gland cancers.

AIM WINNERS & LOSERS: Avacta makes progress on AVA6000 testing

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

Avacta agrees to sell UK-based diagnostics unit

(Sharecast News) - Life sciences firm Avacta revealed on Friday that it has agreed to sell its UK-based diagnostics unit to Duomed Belgium for £12.9m in cash.

Avacta reports promising results from ongoing clinical trial

(Sharecast News) - Avacta Therapeutics announced promising results from its ongoing phase 1a trial of AVA6000 on Thursday, demonstrating meaningful tumour shrinkage in patients with salivary gland cancer (SGC).

EXECUTIVE CHANGES: Various Eateries hires Young's executive as CEO

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and last week and not separately reported by Alliance News:

LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

Peel Hunt starts Avacta at 'buy' with 99p price target

(Sharecast News) - Peel Hunt initiated coverage on Avacta on Thursday with a 'buy' rating and 99p price target as it pointed out three key aspects of the investment case.

Avacta partners with Tempus to enable AI-driven drug development

(Alliance News) - Avacta Group PLC on Monday revealed it has agreed to collaborate with AI-focused precision medicine business, Tempus AI Inc, to optimise its clinical development process and enable "the highest probability of success".

Avacta expands pipeline with two novel preclinical assets

(Alliance News) - Avacta Group PLC on Thursday revealed it has expanded its oncology pipeline with two novel preclinical assets.

EXECUTIVE CHANGES: PHSC co-founder and Deltic Energy CEO depart

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

EARNINGS: Brighton Pier gives downbeat outlook; Seeen "has momentum"

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News:

UK earnings, trading statements calendar - next 7 days

LONDON MARKET MIDDAY: Stocks up as 50 basis point Fed cut looks likely

(Alliance News) - Stock prices in Europe were solidly higher on Tuesday, with the growing belief that the Federal Reserve will enact a 50 basis point rate cut putting markets firmly in a risk-on mood.

AIM WINNERS & LOSERS: Warpaint paints confident picture; Next 15 down

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

LONDON BROKER RATINGS: Berenberg, Peel cut TT Electronics to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: